SPECIAL NOTICE
A -- Biodefense Antivirals and Antibiotics
- Notice Date
- 6/5/2002
- Notice Type
- Special Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700-B Rockledge Drive, MSC 7612 Room 2230, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- Reference-Number-NOT-AI-02-03
- Response Due
- 7/12/2002
- Archive Date
- 7/27/2002
- Point of Contact
- Barbara Shadrick, Senior Contracting Officer, Phone 301-496-7288, Fax 301-402-0972,
- E-Mail Address
-
bs92y@nih.gov
- Description
- The National Institute of Allergy and Infectious Diseases (NIAID) wishes to expedite development of two classes of currently licensed and marketed drugs for treatment of potential agents of bioterrorism: (1) Antiviral drugs for treatment of viral hemorrhagic fevers, and (2) Antibiotics for treatment of anthrax, pneumonic plague, and tularemia. NIAID is interested in receiving letters of interest regarding screening, development, and future licensure from organizations that have candidate drugs and the needed research capabilities. Interested organizations should submit a letter of interest that contains a detailed description of their potential development plans, and their R&D capabilities and interest. The letter of interest along with any supporting documentation shall not exceed 10 pages. Letters of interest will be kept confidential and will help in determining the need for an RFP to support further development, testing, and licensure of these products, and in assembling a potential source list for distribution if an RFP is issued. Submit your response to Barbara Shadrick at the address listed in this Special Notice.
- Place of Performance
- Address: United States
- Record
- SN00088218-W 20020607/020605214001 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |